[Clinical study of dienogest in the treatment of refractory endometriosis-associated pain].

B Xu, Bo Xu, Haiyan Li, H J Li, W L Jia, P Gong, Ping Gong, Yan Zhou, Y Zhou, Y Gao, Yanli Gao, T Sun, Tiantong Sun, Zhilong Liu, Z H Liu, H Y Guo
Zhonghua fu chan ke za zhi · 2021 · vol. 56(3) , pp. 178–184 · doi:10.3760/cma.j.cn112141-20200525-00444 · PMID:33874712 · W3152611653
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Dienogest effectively relieved refractory endometriosis-associated pain with good tolerability, offering an alternative treatment option for patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

DNG could effectively relieve REAP and is a well-tolerated therapy. It may supply an alternative option for patients with REAP.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Female Humans Nandrolone Nandrolone Pain Pain Pain Retrospective Studies Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:43.494969+00:00
License: CC0 · commercial use OK